I-6-Chloro-2-methyl-2H-indazol-5-amine CAS 1893125-36-4 Ubumsulwa >98.0% (LCMS) Ensitrelvir (S-217622) Isithombe Esimaphakathi se-COVID-19

I-6-Chloro-2-methyl-2H-indazol-5-amine CAS 1893125-36-4 Ubumsulwa >98.0% (LCMS) Ensitrelvir (S-217622) I-COVID-19 emaphakathi

Incazelo emfushane:

Igama: 6-Chloro-2-methyl-2H-indazol-5-amine

I-CAS: 1893125-36-4

Ubumsulwa: >98.0% (LCMS)

Ukubukeka: Okunsundu Okukhanyayo ukuya Kokumpunga Okuqinile

I-Intermediate ye-Ensitrelvir (S-217622), COVID-19

Ikhwalithi Ephezulu, Ukukhiqizwa Kwezohwebo

E-Mail: alvin@ruifuchem.com

Thumela i-imeyili kithi

Imininingwane Yomkhiqizo

Imikhiqizo Ehlobene

Omaka bomkhiqizo

Incazelo:

I-Commercial Supply Ensitrelvir (S-217622) Emaphakathi:
I-S-Ethylisothiourea Hydrobromide CAS 1071-37-0
2,4,5-Trifluorobenzyl Bromide CAS 157911-56-3
I-Trimethyloxonium Tetrafluoroborate CAS 420-37-1
I-6-Chloro-2-methyl-2H-indazol-5-amine CAS 1893125-36-4
3-(Chloromethyl)-1-methyl-1H-1,2,4-triazole hydrochloride CAS 135206-76-7
1,3,5-Triazine-2,4(1H,3H)-dione, 3-(1,1-dimethylethyl)-6-(ethylthio)- CAS 1360105-53-8

Chemical Properties:

Igama Lekhemikhali	6-Chloro-2-methyl-2H-indazol-5-amine
Inombolo ye-CAS	1893125-36-4
Inombolo yeCAT	I-RF-PI1506
Isimo Sesitoko	Kukhona kusitoki
I-Molecular Formula	I-C8H8ClN3
Isisindo samangqamuzana	181.62
Ibhrendi	I-Ruifu Chemical

Imininingwane:

Into	Imininingwane
Ukubukeka	Okunsundu Okukhanyayo kuya Kumpunga Okuqinile
Ukuhlanzeka / Indlela Yokuhlaziya	>98.0% (LCMS)
1 H NMR Spectrum	Ihambisana Nesakhiwo
I-LCMS	Ihambisana Nesakhiwo
Ukulahlekelwa Ekumisweni	≤1.00%
Ukungcola Okuphelele	<2.00%
Izinga Lokuhlola	I-Enterprise Standard
Ukusetshenziswa	I-Intermediate ye-Ensitrelvir (S-217622), COVID-19

Iphakheji nesitoreji:

Iphakheji: Ibhodlela, 25kg/Drum, noma ngokwezidingo zekhasimende.

Isimo Sesitoreji:Gcina ezitsheni ezivaliwe endaweni epholile neyomile;Vikela ekukhanyeni nakumswakama.

Izinzuzo:

I-FAQ:

Isicelo:

I-6-Chloro-2-methyl-2H-indazol-5-amine (i-CAS: 1893125-36-4) iphakathi kwe-Ensitrelvir (S-217622).I-Ensitrelvir ka-Shionogi & Co. iyisidakamizwa esilwa namagciwane esisebenza kahle kakhulu esisebenza kanye ne-Pfizer's Paxlovid.I-Oral Xocova (Ensitrelvir), enendlela yokusebenza efanayo neye-Pfizer's Paxlovid (Nirmatrelvir+Ritonavir), iyahluka ngokuthi idinga ukuthathwa kanye kuphela ngosuku, kuyilapho ukusebenza ngempumelelo kokwelapha kwe-ensitrelvir kungabonakali kungaphansi kwe-Paxlovid.Njengesikhumbuzo, i-Nirmatrelvir iphathwa kabili ngosuku, kanye ne-booster emelwe yi-Ritonavir.I-Ensitrelvir ibe iphilisi lokuqala lasekhaya lase-Japan ukwelapha i-COVID-19, okwesithathu ukugunyazwa ngokomthetho e-Japan;ngoFebhuwari 2022.